Point72 (DIFC)’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,158
Closed -$59.4K 1259
2025
Q2
$59.4K Buy
+5,158
New +$61.2K ﹤0.01% 1024
2025
Q1
Sell
-1,882
Closed -$32.6K 1719
2024
Q4
$32.6K Buy
+1,882
New +$36.3K ﹤0.01% 1192

Other funds holding CLB

Point72 (DIFC)'s CLB Position: Q3 2025 in Review

Point72 (DIFC) sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 5,158 shares — an estimated $59.4K sold.

Point72 (DIFC) first reported a position in CLB in Q4 2024 and held it in 2 quarters. The position peaked at $59.4K in Q2 2025. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • Point72 (DIFC) reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 5,158 Core Laboratories shares in Q3 2025, an estimated $59.4K.
  • Point72 (DIFC) first reported a position in Core Laboratories in Q4 2024 and held it in 2 quarters.
  • Point72 (DIFC)'s Core Laboratories position peaked at $59.4K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.